Shlomo Noy
Directeur/Membre du Conseil chez Innovalve Bio Medical Ltd.
Postes actifs de Shlomo Noy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Innovalve Bio Medical Ltd.
 Innovalve Bio Medical Ltd. Medical SpecialtiesHealth Technology Innovalve Bio Medical Ltd. is an Israeli medical device company that specializes in developing catheter-delivered heart valve therapies. Innovalve Bio Medical was founded in 2017 by Boris Orlov and Ehud Raanani, and is currently based in Ramat Gan, IL. The company aims to address the prevalent and progressive disease of Mitral Regurgitation (MR), which affects nearly 1 in 10 people aged 75 and older. MR is a progressive disease that can lead to advanced stages of MR, heart failure, and other complications. Eyal Baror has been the CEO of the company since 2020. | Directeur/Membre du Conseil | 09/08/2018 | - |
Historique de carrière de Shlomo Noy
Anciens postes connus de Shlomo Noy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Medx Xelerator LP
 Medx Xelerator LP Medical SpecialtiesHealth Technology Medx Xelerator LP provides medical devices incubator. The company is headquartered in Or Yehuda, Israel. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
| Israël | 3 |
Opérationnelle
| Director/Board Member | 2 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Medx Xelerator LP
Medx Xelerator LP Medical SpecialtiesHealth Technology Medx Xelerator LP provides medical devices incubator. The company is headquartered in Or Yehuda, Israel. | Health Technology |
Innovalve Bio Medical Ltd.
Innovalve Bio Medical Ltd. Medical SpecialtiesHealth Technology Innovalve Bio Medical Ltd. is an Israeli medical device company that specializes in developing catheter-delivered heart valve therapies. Innovalve Bio Medical was founded in 2017 by Boris Orlov and Ehud Raanani, and is currently based in Ramat Gan, IL. The company aims to address the prevalent and progressive disease of Mitral Regurgitation (MR), which affects nearly 1 in 10 people aged 75 and older. MR is a progressive disease that can lead to advanced stages of MR, heart failure, and other complications. Eyal Baror has been the CEO of the company since 2020. | Health Technology |
- Bourse
- Insiders
- Shlomo Noy
- Expérience
